Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Aug 19, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
89bio, Inc.
| -4.60K |
$8.04 | -$36,992.04 | -1.00% | 456.24K |
Aug 17
| |||||||
Neurogene Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 14
| |||||||
89bio, Inc.
| -27.72K |
$6.42 | -$526,903.38 | -5.69% | 459.17K |
Apr 1
| |||||||
89bio, Inc.
| -4.48K |
$10.76 | -$48,172.52 | -0.91% | 486.89K |
Feb 26
| |||||||
89bio, Inc.
| -4.60K |
$9.74 | -$44,823.48 | -0.93% | 491.37K |
Feb 17
| |||||||
89bio, Inc.
| -12.67K |
$8.45 | -$107,061.50 | -2.57% | 480.97K |
Feb 9
| |||||||
89bio, Inc.
| 144.93K |
$9.80 | -$49,666.40 | +41.56% | 493.65K |
Feb 1 - Feb 5
| |||||||
Neurogene Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 16
| |||||||
89bio, Inc.
| 47.49K |
$11.53 | -$317,201.83 | +15.77% | 348.71K |
Jan 5
| |||||||
89bio, Inc.
|
0
|
$6.57 | -$463,500.00 |
—
| 301.23K |
Dec 29
| |||||||
89bio, Inc.
| -4.50K |
$15.46 | -$69,585.46 | -1.47% | 300.95K |
Aug 17
| |||||||
89bio, Inc.
| 16.81K |
$18.95 | -$313,186.65 | +5.82% | 305.45K |
Jun 30
| |||||||
Neoleukin Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 8
| |||||||
89bio, Inc.
|
0
|
$10.97 | -$271,050.00 |
—
| 286.98K |
Jun 5
| |||||||
89bio, Inc.
| 17.89K |
$15.23 | -$235,196.89 | +6.65% | 286.97K |
Mar 31
| |||||||
89bio, Inc.
| -15.00K |
$16.00 | -$240,000.00 | -5.28% | 269.08K |
Mar 23
| |||||||
89bio, Inc.
| -6.28K |
$13.97 | -$87,717.63 | -2.16% | 284.07K |
Feb 17
| |||||||
89bio, Inc.
| 75K |
—
|
—
| +34.83% | 290.35K |
Feb 9
| |||||||
89bio, Inc.
| -4.08K |
$13.24 | -$53,992.72 | -1.86% | 215.35K |
Feb 5
| |||||||
89bio, Inc.
| 21.81K |
$5.76 | -$66,395.52 | +11.03% | 219.43K |
Sep 28
| |||||||
89bio, Inc.
| 100K |
$1.93 | $193,000.00 | +102.43% | 197.62K |
Sep 8
| |||||||
Neoleukin Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 12
| |||||||
89bio, Inc.
| -4.09K |
$5.23 | -$21,380.24 | -4.09% | 95.96K |
Feb 5
| |||||||
Neoleukin Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 2
| |||||||
Neoleukin Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
89bio, Inc.
| 54.2K |
—
|
—
| +118.22% | 100.05K |
Feb 17
| |||||||
89bio, Inc.
| 7.5K |
$7.05 | $52,850.00 | +19.56% | 45.84K |
Jan 27 - Jan 28
| |||||||
89bio, Inc.
| 7K |
$16.84 | $117,850.00 | +23.33% | 37K |
Jul 7 - Jul 8
| |||||||
89bio, Inc.
| 30K |
—
|
—
|
∞
| 30K |
Feb 5
| |||||||
89bio, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 14
| |||||||
89bio, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Avanir Pharmaceuticals, Inc.
| -15.00K |
$15.00 | -$225,000.00 | -4.72% | 302.81K |
Nov 28
|
Scheduled
| ||||||
Avanir Pharmaceuticals, Inc.
| 94.06K |
—
|
—
| +42.04% | 317.81K |
Nov 10
| |||||||
Avanir Pharmaceuticals, Inc.
| -25.00K |
$11.25 | -$287,500.00 | -4.48% | 533.5K |
Sep 15
|
Scheduled
| ||||||
Avanir Pharmaceuticals, Inc.
| 123.75K |
—
|
—
| +86.54% | 266.75K |
Feb 12
| |||||||
Avanir Pharmaceuticals, Inc.
| 10K |
$2.80 | $28,000.00 | +7.52% | 143K |
Dec 17
| |||||||
Avanir Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Dec 13
| |||||||
Avanir Pharmaceuticals, Inc.
| 10K |
$4.19 | $41,895.00 | +8.13% | 133K |
Nov 4
| |||||||
Avanir Pharmaceuticals, Inc.
| 63K |
—
|
—
| +105.00% | 123K |
Dec 17
| |||||||
Avanir Pharmaceuticals, Inc.
| 10K |
$2.46 | $24,598.00 | +20.00% | 60K |
Dec 13
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. |
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.